Ranbaxy Wants 1st Circ. To Settle Generics Antitrust Question
Ranbaxy Inc. wants the First Circuit to take an immediate look at its bid to dismiss a multidistrict suit accusing the company of gaining an unfair edge by improperly securing approval...To view the full article, register now.
Already a subscriber? Click here to view full article